[Oncologic and related topics].
D000911:Antibodies, Monoclonal; D000918:Antibody Specificity; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003647:Debrisoquin / Q000378:metabolism; D006680:HLA Antigens / Q000235:genetics; D006801:Humans; D006900:Hydroxylation; D007633:Keratins / Q000378:metabolism; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000175:diagnosis; D010039:Otorhinolaryngologic Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D011110:Polymorphism, Genetic; D011480:Protease Inhibitors / Q000652:urine; D012306:Risk; D012878:Skin Neoplasms / Q000175:diagnosis; D014410:Tumor Stem Cell Assay
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D006680:HLA Antigens; D011480:Protease Inhibitors; D007633:Keratins; D003647:Debrisoquin
Onkologische und verwandte Themen.